| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/20/2003 | WO2003013229A2 An animal model for parkinson's disease |
| 02/20/2003 | WO2003013228A2 Biochemistry-related polynucleotides and polypeptides in plants |
| 02/20/2003 | WO2003013227A2 Yield-related polynucleotides and polypeptides in plants |
| 02/20/2003 | WO2003013226A2 Non-transgenic herbicide resistant plants |
| 02/20/2003 | WO2003013225A2 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | WO2003013224A2 Herbicide tolerant cotton plants and methods for producing and identifying same |
| 02/20/2003 | WO2003000851A3 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 02/20/2003 | WO2002101084A3 Scintillation proximity assays for aminoglycoside binding molecules |
| 02/20/2003 | WO2002099381A3 A single-cell biosensor for the measurement of gpcr ligands in a test sample |
| 02/20/2003 | WO2002099138A3 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2002099080A3 Methods for low background cloning of dna using long oligonucleotides |
| 02/20/2003 | WO2002098369A3 Mutant forms of cholera holotoxin as an adjuvant |
| 02/20/2003 | WO2002098360A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 02/20/2003 | WO2002096927A3 Ribozyme based treatment of female reproductive diseases |
| 02/20/2003 | WO2002096262A3 Non-alloying core shell nanoparticles |
| 02/20/2003 | WO2002094980A3 Phytocystatin |
| 02/20/2003 | WO2002094874A3 Internalisation of virus into cells |
| 02/20/2003 | WO2002094862A3 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 02/20/2003 | WO2002092769A3 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 02/20/2003 | WO2002092758A8 Gastrokines and derived peptides including inhibitors |
| 02/20/2003 | WO2002090516A3 Design of artificial genes for use as controls in gene expression analysis systems |
| 02/20/2003 | WO2002090501A3 Vectors having replication, immunogenicity and/or pathogenicity under stress promoter regulation and use thereof |
| 02/20/2003 | WO2002086085A3 Human timp-1 antibodies |
| 02/20/2003 | WO2002083910A3 Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same |
| 02/20/2003 | WO2002083733A3 Polynucleotides and polypeptides of the ifnalpha-6 gene |
| 02/20/2003 | WO2002083080A3 Method of treating arthritis using lentiviral vectors in gene therapy |
| 02/20/2003 | WO2002081628A3 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies |
| 02/20/2003 | WO2002081621A3 Vaccine against the nile fever virus |
| 02/20/2003 | WO2002079464A3 Viral vectors |
| 02/20/2003 | WO2002079423A3 Delta opioid receptor disruptions, compositions and methods related thereto |
| 02/20/2003 | WO2002079387A3 Modular molecular clasps and uses thereof |
| 02/20/2003 | WO2002078621A3 Replication-competent recombinant virus and methods of use thereof |
| 02/20/2003 | WO2002077264A3 Arrayed transfection method and uses related thereto |
| 02/20/2003 | WO2002077242A3 Family 74 xyloglucanases |
| 02/20/2003 | WO2002074953A3 Gene library and a method for producing the same |
| 02/20/2003 | WO2002074156A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 02/20/2003 | WO2002073158A3 Conjugate probes and optical detection of analytes |
| 02/20/2003 | WO2002072871A3 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |
| 02/20/2003 | WO2002072762A3 Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 02/20/2003 | WO2002072019A3 Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases |
| 02/20/2003 | WO2002068645A8 Compositions and methods relating to breast specific genes and proteins |
| 02/20/2003 | WO2002068607A3 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 02/20/2003 | WO2002068605A3 Non-oligomerizing tandem fluorescent proteins |
| 02/20/2003 | WO2002067860A3 Selection by mirror image display |
| 02/20/2003 | WO2002066505A3 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 02/20/2003 | WO2002064758A9 An optical method for testing sensitivity of cells |
| 02/20/2003 | WO2002062976A3 Serine proteases |
| 02/20/2003 | WO2002062850A3 Hybrid antibodies and uses thereof |
| 02/20/2003 | WO2002062821A3 Peptide or protein microassay method and apparatus |
| 02/20/2003 | WO2002062298A3 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 02/20/2003 | WO2002059272A3 Covalent chemical inducers of protein dimerization and their uses in high throughput binding screens |
| 02/20/2003 | WO2002057307A3 Genes |
| 02/20/2003 | WO2002055651A3 Processes and vectors for plastid transformation |
| 02/20/2003 | WO2002052924A3 Method to maintain a genic male-sterile female parental lines for the production of hybrid wheat |
| 02/20/2003 | WO2002052012A8 Sugar beet genes involved in stress tolerance |
| 02/20/2003 | WO2002051978A3 Yeasts transformed by genes enhancing their cold stress tolerance |
| 02/20/2003 | WO2002051351A3 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2002046441A3 Targets for herbicides and transgenic plants resistant to said herbicides |
| 02/20/2003 | WO2002044733A3 Methods and compositions for sorting and/or determining microorganisms |
| 02/20/2003 | WO2002044400A3 Compositions and methods for extracting a nucleic acid |
| 02/20/2003 | WO2002044335A3 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 02/20/2003 | WO2002034929A3 Expression vectors and uses thereof |
| 02/20/2003 | WO2002029088A9 Highly expressible genes |
| 02/20/2003 | WO2002029075A9 Multiple inducible gene regulation system |
| 02/20/2003 | WO2002029070A9 Genetic functions required for gene silencing in maize |
| 02/20/2003 | WO2002028420A9 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 02/20/2003 | WO2002027322A9 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 02/20/2003 | WO2002026950A3 Transferases |
| 02/20/2003 | WO2002026193A9 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 02/20/2003 | WO2002022783A8 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 02/20/2003 | WO2002012332A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 02/20/2003 | WO2002012328A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 02/20/2003 | WO2002010210A3 Polypeptides for identifying herbicidally active compounds |
| 02/20/2003 | WO2002008268A3 Leucine-based motif and clostridial neurotoxins |
| 02/20/2003 | WO2002003791A8 Transgenic mice containing targeted gene disruptions |
| 02/20/2003 | WO2001072325A9 Methods of blocking tissue destruction by autoreactive t cells |
| 02/20/2003 | WO2001066766A3 A matrix metalloproteinase (mmp-25) expressed in skin cell |
| 02/20/2003 | WO2001064949A9 Diagnostics and therapeutics for glaucoma |
| 02/20/2003 | WO2001057271A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells |
| 02/20/2003 | US20030037357 Plant acyl-CoA synthetases |
| 02/20/2003 | US20030037356 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same |
| 02/20/2003 | US20030037355 Methods and compositions to modulate expression in plants |
| 02/20/2003 | US20030037354 Animal model for use in the diagnosis and treatment of nervous system disorders |
| 02/20/2003 | US20030037352 Generation of genetically engineered animal embryos; obtain oocyte, insert into diploid nucleus, activate oocyte, propagate and recover viable offspring |
| 02/20/2003 | US20030037348 Genetic manipulation of spermatogonia |
| 02/20/2003 | US20030037347 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 02/20/2003 | US20030037346 Protein production system |
| 02/20/2003 | US20030037345 Compositions and methods for wound healing |
| 02/20/2003 | US20030037344 Method for evaluating the ability of a compound to inhibit neurotoxicity |
| 02/20/2003 | US20030036649 2' modified oligonucleotides |
| 02/20/2003 | US20030036648 Nucleotide sequences coding polypetide for use in the treatment and prevention of epilepsy, arrhythmia, long QT syndrome, hypertension, respiratory and muscle disorders |
| 02/20/2003 | US20030036646 Uncoupling protein polynucleotides, polypeptides, and antibodies |
| 02/20/2003 | US20030036645 Breast cancer resistance protein (BCRP) and the DNA which encode it |
| 02/20/2003 | US20030036643 Methods and compositions for the construction and use of fusion libraries |
| 02/20/2003 | US20030036642 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 02/20/2003 | US20030036641 Engineering genetic exchange between polynucleotides; obtain nucleotide sequences, generate single stranded nucleotide sequences, fragment, isolate size range of single stranded fragments, anneal to polynucleotide, extend chain |
| 02/20/2003 | US20030036637 Purification of human serum albumin |
| 02/20/2003 | US20030036633 DNA encoding bradykinin B1 receptor |
| 02/20/2003 | US20030036631 Protein for use in the treatment of asthma, leukemia, or other allergic or inflammatory defects |